With this 100% online Master's Degree, you will create personalized intervention plans for the comprehensive management of a wide range of Infectious Diseases” 

Infectious diseases continue to present a global challenge due to their ability to spread and adapt. On one hand, factors such as population mobility, climate change, and antimicrobial resistance have favored the reemergence of Eradicated Diseases. On the other hand, the emergence of new public health threats requires constant updates in knowledge regarding epidemiology and transmission mechanisms. 

In response to this reality, TECH Global University has created an innovative Master's Degree in Infectious Diseases. The syllabus will cover the epidemiology of infectious diseases from a global perspective, analyzing the economic and social conditions that favor their development across various continents. It will also delve into the taxonomy of infectious agents, including viruses, bacteria, fungi, and parasites. Furthermore, the program will explore microbiological identification techniques using microscopy, staining, and cultures, as well as the effects of chemical and physical agents used for sterilization in various clinical settings. Thanks to this approach, the program will enable professionals to acquire specialized knowledge on the factors influencing the spread of these diseases and the most advanced methodologies for their control. 

Moreover, the university degree is based on a flexible 100% online format with free access to educational content. Therefore, graduates will only need an electronic device with internet access to enter the Virtual Campus. Additionally, TECH employs its disruptive Relearning methodology, based on the progressive reiteration of key concepts to facilitate knowledge assimilation without the need for traditional memorization. 

Furthermore, a renowned International Guest Director will offer 10 comprehensive Masterclasses. 

A prestigious International Guest Director will deliver 10 intensive Masterclasses on the most innovative therapeutic methods for managing Infectious Diseases” 

This Master's Degree in Infectious Diseases contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Infectious Diseases 
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice 
• Practical exercises where self-assessment can be used to improve learning 
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an internet connection 

You will deepen your understanding of the pathophysiology, diagnosis, and treatment of the main Infectious Diseases on a global scale” 

The faculty includes professionals from the medical field who share the experience of their work in this program, as well as renowned specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive learning experience designed to prepare for real-life situations. 

This program is designed around Problem-Based Learning, whereby the student must try to solve the different professional practice situations that arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts. 

You will master the early identification of infections caused by viruses, bacteria, fungi, and parasites”

A syllabus tailored to your needs and designed under the most effective teaching methodology: Relearning”

This academic path will provide a comprehensive approach to the analysis of Infectious Diseases, combining epidemiological analysis with clinical methods and evidence-based medicine. Initially, the program will explore the epidemiological, economic, and social conditions that favor the spread of infectious diseases, which will, in turn, facilitate the identification of risk factors and the formulation of preventive strategies. Furthermore, the clinical method will be addressed as an essential tool in diagnosis, preventing errors that could compromise the accuracy of case evaluations. Additionally, competencies in epidemiological surveillance and international health control will be strengthened, enabling the optimization of responses to epidemic outbreaks and ensuring decisions are based on scientific evidence. 

Looking to specialize in the control of Infectious Disease Pathologies? This syllabus will provide you with the key tools to develop highly effective preventive strategies” 

Module 1. Epidemiology of Infectious Diseases

1.1. Epidemiological, Economic, and Social Conditions by Continent that Favor the Development of Infectious Diseases

1.1.1. Africa
1.1.2. America
1.1.3. Europe and Asia

1.2. New and Emerging Diseases By Continent

1.2.1. Morbidity and Mortality from Infectious Diseases in Africa
1.2.2. Morbidity and Mortality from Infectious Diseases in America
1.2.3. Morbidity and Mortality from Infectious Diseases in Asia
1.2.4. Morbidity and Mortality from Infectious Diseases in Europe

1.3. Taxonomy of Infectious Agents

1.3.1. Viruses
1.3.2. Bacteria
1.3.3. Fungi
1.3.4. Parasites

1.4. Properties of Microorganisms to Cause Disease

1.4.1. Pathogenicity Mechanisms
1.4.2. Adhesion and Multiplication Mechanisms
1.4.3. Mechanisms that Allow Nutrient Acquisition from the Host
1.4.4. Mechanisms that Inhibit the Phagocytic Process
1.4.5. Immune Evasion Mechanisms

1.5. Microscopy and Staining

1.5.1. Microscopes and Types of Microscopes
1.5.2. Compound Stains
1.5.3. Staining of Acid-Fast Microorganisms
1.5.4. Stains to Demonstrate Cellular Structures

1.6. Cultures and Growth of Microorganisms

1.6.1. General Culture Media
1.6.2. Specific Culture Media

1.7. Effect of Chemical and Physical Agents on Microorganisms

1.7.1. Sterilization and Disinfection
1.7.2. Disinfectants and Antiseptics Used in Practice

1.8. Molecular Biology and Its Importance for the Infectious Disease Specialist

1.8.1. Bacterial Genetics
1.8.2. Polymerase Chain Reaction Tests

1.9. Indication and Interpretation of Microbiological Studies

Module 2. Clinical Research in Infectious Diseases

2.1. The Clinical Method in the Diagnosis of Infectious Diseases

2.1.1. Fundamental Concepts of the Clinical Method: Stages, Principles
2.1.2. The Clinical Method and Its Utility in Infectious Disease
2.1.3. Most Common Errors in Applying the Clinical Method

2.2. Epidemiology in the Study of Infectious Diseases

2.2.1. Epidemiology as a Science
2.2.2. The Epidemiological Method
2.2.3. Epidemiological Tools Applied to the Study of Infectious Diseases

2.3. Clinical Epidemiology and Evidence-Based Medicine

2.3.1. Scientific Evidence and Clinical Experience
2.3.2. The Importance of Evidence-Based Medicine: Diagnosis and Treatment
2.3.3. Clinical Epidemiology as a Powerful Tool in Medical Thinking

2.4. Behavior of Infectious Diseases in the Population

2.4.1. Endemic
2.4.2. Epidemic
2.4.3. Pandemic

2.5. Addressing Epidemic Outbreaks

2.5.1. Diagnosis of Epidemic Outbreaks
2.5.2. Measures for Controlling Epidemic Outbreaks

2.6. Epidemiological Surveillance

2.6.1. Types of Epidemiological Surveillance
2.6.2. Design of Epidemiological Surveillance Systems
2.6.3. Utility and Importance of Epidemiological Surveillance

2.7. International Health Control

2.7.1. Components of International Health Control
2.7.2. Diseases Subject to International Health Control
2.7.3. Importance of International Health Control

2.8. Mandatory Reporting Systems for Infectious Diseases

2.8.1. Characteristics of Diseases Subject to Mandatory Reporting
2.8.2. The Role of the Physician in Mandatory Reporting Systems for Infectious Diseases

2.9. Vaccination

2.9.1. Immunological Basis of Vaccination
2.9.2. Vaccine Development and Production
2.9.3. Diseases Preventable by Vaccines
2.9.4. Experiences and Results of the Vaccination System in Cuba

2.10. Research Methodology in Health

2.10.1. The Importance of Research Methodology for Public Health as a Science
2.10.2. Scientific Thinking in Health
2.10.3. The Scientific Method
2.10.4. Stages of Scientific Research

2.11. Information Management and Use of New Information and Communication Technologies

2.11.1. Use of New Information and Communication Technologies in Knowledge Management for Health Professionals in Clinical, Teaching, and Research Work
2.11.2. Information Literacy

2.12. Design of Research Studies for Infectious Diseases

2.12.1. Types of Studies in Health and Medical Sciences
2.12.2. Design of Research Applied to Infectious Diseases

2.13. Descriptive and Inferential Statistics

2.13.1. Summary Measures for Various Variables in Scientific Research
2.13.2. Measures of Central Tendency: Mean, Mode, and Median
2.13.3. Dispersion Measures: Variants and Standard Deviation
2.13.4. Statistical Estimation
2.13.5. Population and Sample
2.13.6. Tools for Inferential Statistics

2.14. Design and Use of Databases

2.14.1. Types of Databases
2.14.2. Programs and Statistical Packages for Database Management

2.15. Scientific Research Protocol

2.15.1. Components of a Scientific Research Protocol
2.15.2. Utility of a Scientific Research Protocol

2.16. Clinical Trials and Meta-Analysis

2.16.1. Types of Clinical Trials
2.16.2. The Role of Clinical Trials in Health Research
2.16.3. Meta-Analysis: Conceptual Definitions and Methodological Design
2.16.4. Applicability of Meta-Analysis and Its Role in Medical Sciences

2.17. Critical Reading of Scientific Research

2.17.1. Medical Journals and Their Role in Disseminating Scientific Information
2.17.2. The Most Impactful Medical Journals in Infectious Disease Worldwide
2.17.3. Methodological Tools for Critical Reading of Scientific Literature

2.18. Publication of Scientific Research Results

2.18.1. The Scientific Article
2.18.2. Types of Scientific Articles
2.18.3. Methodological Requirements for Publishing Scientific Research Results
2.18.4. The Process of Scientific Publication in Medical Journals

Module 3. Challenges in the Diagnostic Process of Infectious Diseases

3.1. Diagnosis of Bacteremia, Catheter-Related Infections, and Soft Tissue Infections
3.2. Bacteriological Diagnosis of Bacteremia. Genitourinary Infections
3.3. Concepts and Application of In Vitro Antibiotic Sensitivity Tests. Detection of Resistance Mechanisms
3.4. Microbiological Diagnosis of Mycobacteria
3.5. Mycological Diagnosis and In Vitro Sensitivity Testing
3.6. Virological Diagnosis
3.7. Parasitological Diagnosis
3.8. Procedures in Clinical Practice

3.8.1. Sample Collection: Blood Cultures, Respiratory Samples, Urine, Genital Exudates, Swabs, Surgical Samples and Biopsies, Stool Cultures, etc.
3.8.2. Interpretation of Results: Microbiological Identification (Colonization, Infection, Contamination), Sensitivity Testing, and Serology

Module 4. Advances in Antibiotic Therapy

4.1. Basic Principles in the Selection and Use of Antimicrobials
4.2. Basics of Resistance and Its Clinical Implications
4.3. Clinical Application of PK/PD Parameters
4.4. Use of Antimicrobials in Special Host Situations

Module 5. Rational Use of Antibiotics

5.1. Beta-Lactams I: Penicillins, Aminopenicillins and Beta-Lactamase Inhibitors
5.2. Beta-Lactams II: Cephalosporins, Monobactams and Carbapenems
5.3. Aminoglycosides, Tetracyclines, Lincosamides, Rifamycins, and Antifolates
5.4. Quinolones and Macrolides
5.5. Glycopeptides. New Antibiotics for Gram-positive Infections (Lipopeptides and Oxazolidinones)
5.6. Antifungal Agents
5.7. Antiviral Agents (Excluding Antiretrovirals and Direct-acting Antivirals for HCV)
5.8. Antimicrobial Combinations. Pros and Cons

Module 6. Infectious Diseases of International Travelers

6.1. Vaccination for International Travelers

6.1.1. Main Vaccines for International Travelers
6.1.2. Vaccination Against Yellow Fever

6.2. Prophylaxis for Travellers to Tropical Areas

6.2.1. Pharmacological Treatment Based on the Geographic Area to be Visited
6.2.2. Glucose-6-Phosphate Dehydrogenase Deficiency and Antimalarial Drugs
6.2.3. Traveler Prevention Measures in Tropical Areas

6.3. Traveller’s Diarrhea

6.3.1. Epidemiology
6.3.2. Etiology
6.3.3. Clinical Manifestations
6.3.4. Diagnosis
6.3.5. Treatment

6.4. Health Control for International Travelers
6.5. Fever After International Travell

6.5.1. Main Etiologies
6.5.2. Diagnostic Approach
6.5.3. Imported Infectious Pathology in International Travelers

Module 7. Nosocomial Infections

7.1. Infections Associated with Medical Procedures

7.1.1. Surgical Wound Infection: Superficial and Deep
7.1.2. Nosocomial Pneumonia Associated with Mechanical Ventilation
7.1.3. Infections Associated with Non-Tunneled Peripheral and Central Venous Catheters
7.1.4. Infections Associated with Urinary Catheter
7.1.5. Clostridium Difficile Infection
7.1.6. Overview of Infection in Critically Ill Patients Admitted to the ICU

Module 8. Assessment and Treatment of Community-Acquired Infections

8.1. Assessment of Severity in Infectious Diseases
8.2. The Role of Biomarkers in Clinical Diagnosis of Infection
8.3. Basic Principles for Clinicians in the Assessment and Choice of Empirical Antibiotic Treatment
8.4. Severe Sepsis and Septic Shock: Sepsis Code
8.5. Osteoarticular Infections
8.6. Central Nervous System Infections
8.7. Bacterial Endocarditis

Module 9. Urinary Tract, Skin, and Soft Tissue Infections

9.1. Genital Tract Infections and STDs I
9.2. Genital Tract Infections and STDs II
9.3. Genital Infections in Women
9.4. Urinary Tract Infections
9.5. Viral Skin Infections
9.6. Fungal and Mycobacterial Skin Infections
9.7. Bacterial Skin and Soft Tissue Infections
9.8. Intra-abdominal and Enteric Infections

Module 10. Zoonotic and Bacterial Infections

10.1. Tuberculosis
10.2. Community-Acquired Pneumonia (CAP)
10.3. Zoonoses (Brucella, Rickettsia, Bartonella, Leptospira, Lyme, Leishmania, Arbovirus,etc.)
10.4. Intermediate Febrile Syndrome
10.5. Mononucleosis Syndrome
10.6. Fever and Exanthema
10.7. Fever and Lymphadenopathies in Immunocompetent Patients
10.8. Fever of Unknown Origin (FUO) in the 21st Century

Module 11. Hepatitis, HIV/AIDS Coinfection, and Tuberculosis

11.1. Viral Hepatitis A

11.1.1. Virus Characteristics and Replication Cycle
11.1.2. Clinical Picture
11.1.3. Viral Markers
11.1.4. Evolution and Prognosis
11.1.5. Treatment

11.2. Viral Hepatitis B and C

11.2.1. Virus Characteristics and Replication Cycle
11.2.2. Clinical Picture
11.2.3. Viral Markers
11.2.4. Evolution and Prognosis
11.2.5. Treatment

11.3. Viral Hepatitis D and E

11.3.1. Virus Characteristics and Replication Cycle
11.3.2. Clinical Picture
11.3.3. Viral Markers
11.3.4. Evolution and Prognosis
11.3.5. Treatment

11.4. Epidemiology of Morbidity and Mortality from Tuberculosis and HIV/AIDS Coinfection

11.4.1. Incidence
11.4.2. Prevalence
11.4.3. Mortality

11.5. Pathobiology of Tuberculosis and HIV/AIDS Coinfection

11.5.1. Pathophysiological Alterations in Coinfection
11.5.2. Pathological Alterations

11.6. Clinical Manifestations of Coinfection

11.6.1. Clinical Manifestations of Pulmonary Tuberculosis
11.6.2. Clinical Manifestations of Extrapulmonary Tuberculosis

11.7. Diagnosis of Tuberculosis in Patients Living with HIV/AIDS

11.7.1. Diagnostic Studies for Pulmonary Tuberculosis in HIV/AIDS Patients

11.8. Comprehensive Care for Patients with Tuberculosis and HIV/AIDS Coinfection and Therapeutic Considerations

11.8.1. Comprehensive Care System for TB/HIV/AIDS Patients
11.8.2. Considerations in Antituberculosis Treatment for Patients with Tuberculosis and HIV/AIDS Coinfection
11.8.3. Considerations in Antiretroviral Treatment for Patients with Tuberculosis and HIV/AIDS Coinfection
11.8.4. The Issue of Resistance to Antitubercular and Antiretroviral Drugs in These Patients

Module 12. Parasitic and Tropical Diseases

12.1. Introduction to Parasitology

12.1.1. General Concepts Used in Parasitology
12.1.2. Epidemiology of Major Parasitic Diseases and Tropical Diseases
12.1.3. Classification of Parasites
12.1.4. Tropical Diseases and Febrile Syndrome in the Tropics

12.2. Malaria

12.2.1. Epidemiology
12.2.2. Etiological Agent
12.2.3. Pathogenesis
12.2.4. Clinical Picture
12.2.5. Complications
12.2.6. Diagnosis
12.2.7. Treatment

12.3. Intestinal Protozoan Infections

12.3.1. Main Intestinal Protozoa
12.3.2. Diagnosis of Intestinal Protozoa
12.3.3. Amebiasis and Giardiasis

12.4. Filarial Diseases

12.4.1. Epidemiology and Global Situation
12.4.2. Clinical Syndromes
12.4.3. Main Filarial Diseases: Main Filariae: Wuchereria Bancrofti, Brugia Malayi, Brugia Timori, Onchocerca Volvulus, Loa Loa, Mansonella Perstans, Mansonella Streptocerca, and Mansonella Ozzardi

12.5. Leishmaniasis

12.5.1. Cutaneous Leishmaniasis
12.5.2. Visceral Leishmaniasis

12.6. Trypanosomiasis

12.6.1. African Trypanosomiasis
12.6.2. American Trypanosomiasis

12.7. Schistosomiasis

12.7.1. Schistosomiasis Haematobium
12.7.2. Schitosomiosis Mansoni
12.7.3. Schitosomiosis Japonicum
12.7.4. Schitosomiosis Intercalatum

12.8. Intestinal Parasitism

12.8.1. Epidemiology
12.8.2. Ascariasis
12.8.3. Enterobiasis
12.8.4. Hookworm Infection and Necatoriasis
12.8.5. Trichuriasis

12.9. Tapeworm Infections

12.9.1. Intestinal Tapeworms
12.9.2. Tissue Tapeworms

12.10. Antiparasitic Agents

12.10.1. General Concepts
12.10.2. Main Definitions Used in the Management of Antiparasitics
12.10.3. Classifications Based on Chemical Structure, Mechanism of Action, or Antiparasitic Action
12.10.4. Mechanisms of Action

12.11. Antiprotozoals

12.11.1. Classification
12.11.2. Mechanisms of Action
12.11.3. Antiparasitic Spectrum
12.11.4. Pharmacokinetics and Pharmacodynamics
12.11.5. Dosage and Presentation

12.12. Antiparasitic for Helminths

12.12.1. Classification
12.12.2. Mechanisms of Action
12.12.3. Antiparasitic Spectrum
12.12.4. Pharmacokinetics and Pharmacodynamics
12.12.5. Dosage and Presentation

Module 13. Antimicrobial Resistance

13.1. Epidemiology. From Molecular to Socioeconomic

13.1.1. Analysis of the Molecular, Genetic, Clinical, Epidemiological, and Socioeconomic Evolution of Antibiotic Resistance
13.1.2. Mortality from Superbugs
13.1.3. Most Lethal Superbugs

13.2. Mechanisms of Antimicrobial Resistance

13.2.1. Genetic Mechanisms
13.2.2. Acquired Mechanisms

13.3. MRSA and GISA

13.3.1. Epidemiology
13.3.2. Resistance Mechanisms
13.3.3. Therapeutic Alternatives

13.4. Resistant Enterobacteria

13.4.1. Epidemiology
13.4.2. Resistance Mechanisms
13.4.3. Therapeutic Alternatives

13.5. Resistant Pneumococcus

13.5.1. Epidemiology
13.5.2. Resistance Mechanisms
13.5.3. Therapeutic Alternatives

13.6. Viral Resistance

13.6.1. Epidemiology
13.6.2. Resistance Mechanisms
13.6.3. Therapeutic Alternatives

13.7. Fungal and Parasitic Resistance

13.7.1. Epidemiology
13.7.2. Resistance Mechanisms
13.7.3. Therapeutic Alternatives

13.8. Global Program for the Control of Antimicrobial Resistance and the Research of New Antibiotics

13.8.1. Objectives and Actions of the Global Program for the Control of Antimicrobial Resistance
13.8.2. Research on New Antibiotics for Multidrug-resistant Germs
13.8.3. Emergence of Other Therapeutic Modalities for Infection Control

Module 14. ICT and the Medical History in Infectious Diseases

14.1. Clinical Decision Support Systems
14.2. Information Systems and Antimicrobial Optimization Programs
14.3. Record and Surveillance Systems

Module 15. Coronavirus Infections

15.1. Discovery and Evolution of Coronaviruses

15.1.1. Discovery of Coronaviruses
15.1.2. Global Trends in Coronavirus Infections

15.2. Main Microbiological Characteristics and Members of the Coronavirus Family

15.2.1. General Microbiological Characteristics of Coronaviruses
15.2.2. Viral Genome
15.2.3. Principal Virulence Factors

15.3. Epidemiological Changes in Coronavirus Infections from Its Discovery to the Present

15.3.1. Morbidity and Mortality of Coronavirus Infections from their Emergence to the Present

15.4. The Immune System and Coronavirus Infections

15.4.1. Immunological Mechanisms Involved in the Immune Response to Coronaviruses
15.4.2. Cytokine Storm in Coronavirus Infections and Immunopathology
15.4.3. Modulation of the Immune System in Coronavirus Infections

15.5. Pathogenesis and Pathophysiology of Coronavirus Infections

15.5.1. Pathophysiological and Pathogenic Alterations in Coronavirus Infections
15.5.2. Clinical Implications of the Main Pathophysiological Alterations

15.6. Risk Groups and Transmission Mechanisms of Coronaviruses

15.6.1. Main Sociodemographic and Epidemiological Characteristics of Risk Groups Affected by Coronavirus
15.6.2. Coronavirus Mechanisms of Transmission

15.7. Natural History of Coronavirus Infections

15.7.1. Stages of Coronavirus Infection

15.8. Updated Microbiological Diagnosis of Coronavirus Infections

15.8.1. Sample Collection and Shipment
15.8.2. PCR and Sequencing
15.8.3. Serology Testing
15.8.4. Virus Isolation

15.9. Current Biosafety Measures in Microbiology Laboratories for Coronavirus Sample Handling

15.9.1. Biosafety Measures for Coronavirus Sample Handling

15.10. Up-to-Date Management of Coronavirus Infections

15.10.1. Prevention Measures
15.10.2. Symptomatic Treatment
15.10.3. Antiviral and Antimicrobial Treatment in Coronavirus Infections
15.10.4. Treatment of Severe Clinical Forms

15.11. Future Challenges in Prevention, Diagnosis, and Therapy of Coronavirus Infections

15.11.1. Global Challenges for the Development of Prevention, Diagnostic, and Treatment Strategies for Coronavirus Infections

You will detect the fundamental properties of pathogenic microorganisms, delving into how chemical and physical agents influence their virulence”